UK’s MHRA opens consultation on statutory fees

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced that it is seeking views from interested stakeholders on proposals to update its statutory fees to ensure they continue to recover their costs.

The MHRA’s fees are updated on a regular basis to ensure they continue to achieve full cost-recovery in line with HM Treasury guidance ‘Managing Public Money’.

This is necessary for long-term financial sustainability and the ongoing delivery of the MHRA’s services.